Cutting-Edge Nanocarrier-Based Strategies in the Management of Leukaemia
- 1st Edition - February 17, 2026
- Latest edition
- Editors: Devesh U. Kapoor, Bhupendra G. Prajapati, Anand Krishnan
- Language: English
Cutting-edge Nanocarrier-Based Strategies in the Management of Leukaemia addresses the importance of nanocarriers in leukemia treatment. The book explores advancements in nanote… Read more
Robotics & automation week
Empowering Progress
Up to 20% on Robotics and Automation Resources!
- Provides an in-depth exploration of various nanocarrier-based therapies for leukemia
- Integrates perspectives from multiple fields, such as nanotechnology, artificial intelligence, and personalized medicine
- Enhances comprehension and provides practical insights, helping readers better understand and apply the discussed therapies in clinical settings
2. siRNA and miRNA therapies for leukaemia
3. Gene therapy for leukaemia
4. Exploring Polymeric nanoparticles in leukaemia management
5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions
6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy
7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress
8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery
9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications
10. Advances in Leukemia Treatment using Micelles and Dendrimers
11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy
12. Biological and immunological aspects of nanocarriers and nano-vaccines
13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer
- Edition: 1
- Latest edition
- Published: February 17, 2026
- Language: English
DK
Devesh U. Kapoor
BP
Bhupendra G. Prajapati
AK
Anand Krishnan
Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.